KLK3 and posterior cortical atrophy: Although most of the PCa followed an indolent course with an estimated 5-year survival rate of 98.9% as well as the widely usage of prostate-specific antigen (PSA) plus digital rectal examination (DRE) in screening, it still ranked second leading cause of mortality in the western countries [2].